Gambina G

References (7)

Title : Effectiveness of switching to the rivastigmine transdermal patch from oral cholinesterase inhibitors: a naturalistic prospective study in Alzheimer's disease - Cagnin_2015_Neurol.Sci_36_457
Author(s) : Cagnin A , Cester A , Costa B , Ermani M , Gabelli C , Gambina G
Ref : Neurol Sci , 36 :457 , 2015
Abstract : Cagnin_2015_Neurol.Sci_36_457
ESTHER : Cagnin_2015_Neurol.Sci_36_457
PubMedSearch : Cagnin_2015_Neurol.Sci_36_457
PubMedID: 25394739

Title : Sex and ESR1 genotype may influence the response to treatment with donepezil and rivastigmine in patients with Alzheimer's disease - Scacchi_2014_Int.J.Geriatr.Psychiatry_29_610
Author(s) : Scacchi R , Gambina G , Broggio E , Corbo RM
Ref : Int J Geriatr Psychiatry , 29 :610 , 2014
Abstract : Scacchi_2014_Int.J.Geriatr.Psychiatry_29_610
ESTHER : Scacchi_2014_Int.J.Geriatr.Psychiatry_29_610
PubMedSearch : Scacchi_2014_Int.J.Geriatr.Psychiatry_29_610
PubMedID: 24150894

Title : Variability of AChE, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and Rivastigmine - Scacchi_2009_Am.J.Med.Genet.B.Neuropsychiatr.Genet_150B_502
Author(s) : Scacchi R , Gambina G , Moretto G , Corbo RM
Ref : American Journal of Medicine Genet B Neuropsychiatr Genet , 150B :502 , 2009
Abstract : Scacchi_2009_Am.J.Med.Genet.B.Neuropsychiatr.Genet_150B_502
ESTHER : Scacchi_2009_Am.J.Med.Genet.B.Neuropsychiatr.Genet_150B_502
PubMedSearch : Scacchi_2009_Am.J.Med.Genet.B.Neuropsychiatr.Genet_150B_502
PubMedID: 18780301

Title : Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease - Blesa_2006_Pharmacogenet.Genomics_16_771
Author(s) : Blesa R , Bullock R , He Y , Bergman H , Gambina G , Meyer J , Rapatz G , Nagel J , Lane R
Ref : Pharmacogenet Genomics , 16 :771 , 2006
Abstract : Blesa_2006_Pharmacogenet.Genomics_16_771
ESTHER : Blesa_2006_Pharmacogenet.Genomics_16_771
PubMedSearch : Blesa_2006_Pharmacogenet.Genomics_16_771
PubMedID: 17047484

Title : Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease - Bullock_2006_Curr.Med.Res.Opin_22_483
Author(s) : Bullock R , Bergman H , Touchon J , Gambina G , He Y , Nagel J , Lane R
Ref : Curr Med Res Opin , 22 :483 , 2006
Abstract : Bullock_2006_Curr.Med.Res.Opin_22_483
ESTHER : Bullock_2006_Curr.Med.Res.Opin_22_483
PubMedSearch : Bullock_2006_Curr.Med.Res.Opin_22_483
PubMedID: 16574032

Title : Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period - Bullock_2005_Curr.Med.Res.Opin_21_1317
Author(s) : Bullock R , Touchon J , Bergman H , Gambina G , He Y , Rapatz G , Nagel J , Lane R
Ref : Curr Med Res Opin , 21 :1317 , 2005
Abstract : Bullock_2005_Curr.Med.Res.Opin_21_1317
ESTHER : Bullock_2005_Curr.Med.Res.Opin_21_1317
PubMedSearch : Bullock_2005_Curr.Med.Res.Opin_21_1317
PubMedID: 16083542

Title : Acetylcholinesterase assay may predict cognitive response of Alzheimer patients to eptastigmine treatment [letter] -
Author(s) : Imbimbo BP , Nicoli M , Martini C , Tomelleri GP , Martelli P , Ferrari GP , Gambina G
Ref : European Journal of Clinical Pharmacology , 54 :809 , 1998
PubMedID: 9923589